Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

SUMO1 regulates endothelial function by modulating the overall signals in favor of angiogenesis and homeostatic responses.

Yang P, Zhang Y, Xu J, Zhang S, Yu Q, Pang J, Rao X, Kuczma M, Marrero MB, Fulton D, Kraj P, Su Y, Wang CY.

Am J Transl Res. 2013 May 24;5(4):427-40. Print 2013.

2.

Alpha7 nicotinic receptors as novel therapeutic targets for inflammation-based diseases.

Bencherif M, Lippiello PM, Lucas R, Marrero MB.

Cell Mol Life Sci. 2011 Mar;68(6):931-49. doi: 10.1007/s00018-010-0525-1. Epub 2010 Oct 15. Review.

3.

Application of alpha7 nicotinic acetylcholine receptor agonists in inflammatory diseases: an overview.

Marrero MB, Bencherif M, Lippiello PM, Lucas R.

Pharm Res. 2011 Feb;28(2):413-6. doi: 10.1007/s11095-010-0283-7. Epub 2010 Sep 22. Review.

PMID:
20859658
4.

Molecular mechanism of angiotensin II-induced insulin resistance in aortic vascular smooth muscle cells: roles of Protein Tyrosine Phosphatase-1B.

Ketsawatsomkron P, Stepp DW, Fulton DJ, Marrero MB.

Vascul Pharmacol. 2010 Sep-Oct;53(3-4):160-8. doi: 10.1016/j.vph.2010.06.001. Epub 2010 Jun 25.

5.

Stretch-activated cation channel from larval bullfrog skin.

Hillyard SD, Willumsen NJ, Marrero MB.

J Exp Biol. 2010 May;213(Pt 10):1782-7. doi: 10.1242/jeb.040568.

6.

Deletion of protein tyrosine phosphatase 1b improves peripheral insulin resistance and vascular function in obese, leptin-resistant mice via reduced oxidant tone.

Ali MI, Ketsawatsomkron P, Belin de Chantemele EJ, Mintz JD, Muta K, Salet C, Black SM, Tremblay ML, Fulton DJ, Marrero MB, Stepp DW.

Circ Res. 2009 Nov 6;105(10):1013-22. doi: 10.1161/CIRCRESAHA.109.206318. Epub 2009 Sep 24.

7.

An alpha7 nicotinic acetylcholine receptor-selective agonist reduces weight gain and metabolic changes in a mouse model of diabetes.

Marrero MB, Lucas R, Salet C, Hauser TA, Mazurov A, Lippiello PM, Bencherif M.

J Pharmacol Exp Ther. 2010 Jan;332(1):173-80. doi: 10.1124/jpet.109.154633. Epub 2009 Sep 28.

PMID:
19786623
8.

Protein tyrosine phosphatase 1B, a major regulator of leptin-mediated control of cardiovascular function.

Belin de Chantemèle EJ, Muta K, Mintz J, Tremblay ML, Marrero MB, Fulton DJ, Stepp DW.

Circulation. 2009 Sep 1;120(9):753-63. doi: 10.1161/CIRCULATIONAHA.109.853077. Epub 2009 Aug 17.

9.

Convergence of alpha 7 nicotinic acetylcholine receptor-activated pathways for anti-apoptosis and anti-inflammation: central role for JAK2 activation of STAT3 and NF-kappaB.

Marrero MB, Bencherif M.

Brain Res. 2009 Feb 23;1256:1-7. doi: 10.1016/j.brainres.2008.11.053. Epub 2008 Nov 27.

PMID:
19063868
10.

Paradoxical activation of endothelial nitric oxide synthase by NADPH oxidase.

Zhang Q, Malik P, Pandey D, Gupta S, Jagnandan D, Belin de Chantemele E, Banfi B, Marrero MB, Rudic RD, Stepp DW, Fulton DJ.

Arterioscler Thromb Vasc Biol. 2008 Sep;28(9):1627-33. doi: 10.1161/ATVBAHA.108.168278. Epub 2008 Jun 12.

11.

Angiotensin II-induced signaling pathways in diabetes.

Marrero MB, Fulton D, Stepp D, Stern DM.

Curr Diabetes Rev. 2005 May;1(2):197-202. Review.

PMID:
18220595
12.

Angiotensin II and endothelin-1 augment the vascular complications of diabetes via JAK2 activation.

Banes-Berceli AK, Ketsawatsomkron P, Ogbi S, Patel B, Pollock DM, Marrero MB.

Am J Physiol Heart Circ Physiol. 2007 Aug;293(2):H1291-9. Epub 2007 May 25.

13.

P2 receptor regulation of [Ca2+]i in cultured mouse mesangial cells.

Rivera I, Zhang S, Fuller BS, Edwards B, Seki T, Wang MH, Marrero MB, Inscho EW.

Am J Physiol Renal Physiol. 2007 May;292(5):F1380-9. Epub 2007 Jan 9.

14.

Novel mechanism of activation of NADPH oxidase 5. calcium sensitization via phosphorylation.

Jagnandan D, Church JE, Banfi B, Stuehr DJ, Marrero MB, Fulton DJ.

J Biol Chem. 2007 Mar 2;282(9):6494-507. Epub 2006 Dec 12.

15.

Role of the JAK/STAT signaling pathway in diabetic nephropathy.

Marrero MB, Banes-Berceli AK, Stern DM, Eaton DC.

Am J Physiol Renal Physiol. 2006 Apr;290(4):F762-8. Review.

16.
17.

Effect of simvastatin on high glucose- and angiotensin II-induced activation of the JAK/STAT pathway in mesangial cells.

Banes-Berceli AK, Shaw S, Ma G, Brands M, Eaton DC, Stern DM, Fulton D, Caldwell RW, Marrero MB.

Am J Physiol Renal Physiol. 2006 Jul;291(1):F116-21. Epub 2006 Jan 31.

18.

Endothelin-1 activation of JAK2 in vascular smooth muscle cells involves NAD(P)H oxidase-derived reactive oxygen species.

Banes-Berceli AK, Ogobi S, Tawfik A, Patel B, Shirley A, Pollock DM, Fulton D, Marrero MB.

Vascul Pharmacol. 2005 Nov;43(5):310-9.

PMID:
16290054
19.

Introduction to JAK/STAT signaling and the vasculature.

Marrero MB.

Vascul Pharmacol. 2005 Nov;43(5):307-9. Epub 2005 Nov 2. No abstract available.

PMID:
16263337
20.

Hyperglycemia and reactive oxygen species mediate apoptosis in aortic endothelial cells through Janus kinase 2.

Tawfik A, Jin L, Banes-Berceli AK, Caldwell RB, Ogbi S, Shirley A, Barber D, Catravas JD, Stern DM, Fulton D, Caldwell RW, Marrero MB.

Vascul Pharmacol. 2005 Nov;43(5):320-6. Epub 2005 Oct 27.

PMID:
16257269
21.

Aldose reductase pathway mediates JAK-STAT signaling: a novel axis in myocardial ischemic injury.

Hwang YC, Shaw S, Kaneko M, Redd H, Marrero MB, Ramasamy R.

FASEB J. 2005 May;19(7):795-7. Epub 2005 Mar 3.

PMID:
15746188
22.

Activation of the JAK/STAT pathway in vascular smooth muscle by serotonin.

Banes AK, Shaw SM, Tawfik A, Patel BP, Ogbi S, Fulton D, Marrero MB.

Am J Physiol Cell Physiol. 2005 Apr;288(4):C805-12. Epub 2004 Dec 15.

23.

Angiotensin II-induced insulin resistance and protein tyrosine phosphatases.

Marrero MB, Fulton D, Stepp D, Stern DM.

Arterioscler Thromb Vasc Biol. 2004 Nov;24(11):2009-13. Epub 2004 Jul 22. Review.

PMID:
15271787
24.

Insulin resistance does not diminish eNOS expression, phosphorylation, or binding to HSP-90.

Fulton D, Harris MB, Kemp BE, Venema RC, Marrero MB, Stepp DW.

Am J Physiol Heart Circ Physiol. 2004 Dec;287(6):H2384-93. Epub 2004 Jul 22.

25.

The neuroprotective effect of 2-(3-pyridyl)-1-azabicyclo[3.2.2]nonane (TC-1698), a novel alpha7 ligand, is prevented through angiotensin II activation of a tyrosine phosphatase.

Marrero MB, Papke RL, Bhatti BS, Shaw S, Bencherif M.

J Pharmacol Exp Ther. 2004 Apr;309(1):16-27. Epub 2004 Jan 13.

PMID:
14722323
26.

Angiotensin II blockade prevents hyperglycemia-induced activation of JAK and STAT proteins in diabetic rat kidney glomeruli.

Banes AK, Shaw S, Jenkins J, Redd H, Amiri F, Pollock DM, Marrero MB.

Am J Physiol Renal Physiol. 2004 Apr;286(4):F653-9. Epub 2003 Dec 16.

28.

S100B-RAGE-mediated augmentation of angiotensin II-induced activation of JAK2 in vascular smooth muscle cells is dependent on PLD2.

Shaw SS, Schmidt AM, Banes AK, Wang X, Stern DM, Marrero MB.

Diabetes. 2003 Sep;52(9):2381-8.

29.

VEGF differentially activates STAT3 in microvascular endothelial cells.

Bartoli M, Platt D, Lemtalsi T, Gu X, Brooks SE, Marrero MB, Caldwell RB.

FASEB J. 2003 Aug;17(11):1562-4. Epub 2003 Jun 17.

PMID:
12824281
30.

High glucose augments the angiotensin II-induced activation of JAK2 in vascular smooth muscle cells via the polyol pathway.

Shaw S, Wang X, Redd H, Alexander GD, Isales CM, Marrero MB.

J Biol Chem. 2003 Aug 15;278(33):30634-41. Epub 2003 May 30.

31.
32.

Janus kinase 2, an early target of alpha 7 nicotinic acetylcholine receptor-mediated neuroprotection against Abeta-(1-42) amyloid.

Shaw S, Bencherif M, Marrero MB.

J Biol Chem. 2002 Nov 22;277(47):44920-4. Epub 2002 Sep 18.

33.
34.

Angiotensin II activation of the JAK/STAT pathway in mesangial cells is altered by high glucose.

Amiri F, Shaw S, Wang X, Tang J, Waller JL, Eaton DC, Marrero MB.

Kidney Int. 2002 May;61(5):1605-16.

35.

Vascular endothelial growth factor activates STAT proteins in aortic endothelial cells.

Bartoli M, Gu X, Tsai NT, Venema RC, Brooks SE, Marrero MB, Caldwell RB.

J Biol Chem. 2000 Oct 27;275(43):33189-92.

36.

Interleukin-4 mediates STAT6 activation in 3T3-L1 preadipocytes but not adipocytes.

Deng J, Hua K, Lesser SS, Greiner AH, Walter AW, Marrero MB, Harp JB.

Biochem Biophys Res Commun. 2000 Jan 19;267(2):516-20.

PMID:
10631093
37.

Hyperglycemia enhances angiotensin II-induced janus-activated kinase/STAT signaling in vascular smooth muscle cells.

Amiri F, Venema VJ, Wang X, Ju H, Venema RC, Marrero MB.

J Biol Chem. 1999 Nov 5;274(45):32382-6.

38.

Endothelial nitric oxide synthase interactions with G-protein-coupled receptors.

Marrero MB, Venema VJ, Ju H, He H, Liang H, Caldwell RB, Venema RC.

Biochem J. 1999 Oct 15;343 Pt 2:335-40.

39.

Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src.

He H, Venema VJ, Gu X, Venema RC, Marrero MB, Caldwell RB.

J Biol Chem. 1999 Aug 27;274(35):25130-5.

40.

Regulation of angiotensin II-induced phosphorylation of STAT3 in vascular smooth muscle cells.

Liang H, Venema VJ, Wang X, Ju H, Venema RC, Marrero MB.

J Biol Chem. 1999 Jul 9;274(28):19846-51.

41.

Immunolocalization of phospholipase C isoforms in rat kidney.

Lea JP, Ertoy D, Hollis JL, Marrero MB, Sands JM.

Kidney Int. 1998 Nov;54(5):1484-90.

42.

Inhibition by the JAK/STAT pathway of IFNgamma- and LPS-stimulated nitric oxide synthase induction in vascular smooth muscle cells.

Marrero MB, Venema VJ, He H, Caldwell RB, Venema RC.

Biochem Biophys Res Commun. 1998 Nov 18;252(2):508-12.

PMID:
9826561
43.

Regulation of angiotensin II-induced JAK2 tyrosine phosphorylation: roles of SHP-1 and SHP-2.

Marrero MB, Venema VJ, Ju H, Eaton DC, Venema RC.

Am J Physiol. 1998 Nov;275(5):C1216-23. doi: 10.1152/ajpcell.1998.275.5.C1216.

PMID:
9814969
45.

Inhibitory interactions of the bradykinin B2 receptor with endothelial nitric-oxide synthase.

Ju H, Venema VJ, Marrero MB, Venema RC.

J Biol Chem. 1998 Sep 11;273(37):24025-9.

46.

Phosphorylation of p130Cas by angiotensin II is dependent on c-Src, intracellular Ca2+, and protein kinase C.

Sayeski PP, Ali MS, Harp JB, Marrero MB, Bernstein KE.

Circ Res. 1998 Jun 29;82(12):1279-88.

PMID:
9648724
47.

Characterization of fatty acid synthase in cell lines derived from experimental mammary tumors.

Hennigar RA, Pochet M, Hunt DA, Lukacher AE, Venema VJ, Seal E, Marrero MB.

Biochim Biophys Acta. 1998 May 20;1392(1):85-100.

PMID:
9593836
48.

Bradykinin stimulates the tyrosine phosphorylation and bradykinin B2 receptor association of phospholipase C gamma 1 in vascular endothelial cells.

Venema VJ, Ju H, Sun J, Eaton DC, Marrero MB, Venema RC.

Biochem Biophys Res Commun. 1998 May 8;246(1):70-5.

PMID:
9600070
49.

Erythropoietin receptor-operated Ca2+ channels: activation by phospholipase C-gamma 1.

Marrero MB, Venema RC, Ma H, Ling BN, Eaton DC.

Kidney Int. 1998 May;53(5):1259-68.

50.

Angiotensin II-induced association of phospholipase Cgamma1 with the G-protein-coupled AT1 receptor.

Venema RC, Ju H, Venema VJ, Schieffer B, Harp JB, Ling BN, Eaton DC, Marrero MB.

J Biol Chem. 1998 Mar 27;273(13):7703-8.

Supplemental Content

Loading ...
Support Center